Comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy: a network meta-analysis

BACKGROUND: We performed a network meta-analysis of randomized controlled trials (RCTs) to indirectly compare the efficacy of different targeted agents with fulvestrant for patients with hormone-receptor-positive (HR+) and human epidermal growth factor receptor type 2-negative (HER2–) advanced breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tingting, Feng, Fubin, Zhao, Wenge, Yao, Yan, Tian, Jinhui, Zhou, Chao, Zang, Chuanxin, Liu, Cun, Wang, Xue, Sun, Changgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248378/
https://www.ncbi.nlm.nih.gov/pubmed/30510455
http://dx.doi.org/10.2147/CMAR.S176172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248378/
https://www.ncbi.nlm.nih.gov/pubmed/30510455
http://dx.doi.org/10.2147/CMAR.S176172

Ejemplares similares